BioPharma Credit PLC (LON:BPCR)
London · Delayed Price · Currency is GBP · Price in USD 0.8720
+0.0040 (0.46%)
Aug 5, 2025, 4:35 PM BST
BioPharma Credit Market Cap
BioPharma Credit has a market cap or net worth of 740.37 million as of August 5, 2025. Its market cap has decreased by -11.10% in one year.
Market Cap
740.37M
Enterprise Value
736.15M
Revenue
119.84M
Ranking
n/a
PE Ratio
8.72
Stock Price
0.87
Market Cap Chart
Since March 27, 2017, BioPharma Credit's market cap has increased from 432.35M to 740.37M, an increase of 71.24%. That is a compound annual growth rate of 6.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 738.16M | -11.94% |
| Dec 31, 2024 | 838.24M | -2.43% |
| Dec 29, 2023 | 859.07M | -17.41% |
| Dec 30, 2022 | 1.04B | 5.90% |
| Dec 31, 2021 | 982.16M | -2.00% |
| Dec 31, 2020 | 1.00B | -5.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HSBC Holdings | 160.27B |
| Barclays | 50.99B |
| London Stock Exchange Group | 50.72B |
| Lloyds Banking Group | 48.94B |
| NatWest Group | 42.25B |
| 3i Group | 39.71B |
| Standard Chartered | 31.63B |
| Prudential | 24.35B |